Companion Diagnostics Market is anticipated to expand at a CAGR of 20.0% Forecast Period
During the forecast period of 2022–2030, the global companion diagnostics market is
anticipated to expand at a CAGR of 20.0%.
An in vitro medical device known as a companion
diagnostic is used in conjunction with a therapeutic drug to evaluate the
impact and applicability of the medicine on patients. In order to give safe and
efficient medical treatment, it makes use of a variety of tests and therapies
to provide vital information regarding comparable medicinal medications or
biological products. These diagnostics also give medical practitioners a
thorough understanding of disease biology and the mechanism of action (MOA),
which helps them assess any dangers or side effects that a therapeutic product
might have on particular human bodies.
Download
Request for Sample@ https://www.xresearch.biz/request-sample-pages/companion-diagnostics-market
GROWTH
DRIVERS:
Companion diagnostics are increasingly important in drug
development due to a number of benefits they provide. Other factors include the
growing demand for in-vitro diagnostics and targeted therapies, the rising
demand for next-generation sequencing, the rising number of clinical trials,
the growing development of new biomarkers for various diseases, and the rising
cases of adverse drug reactions related to companion diagnostics.
Additionally, during the past few decades, the incidence
of various cancer cases has increased globally at an unprecedented rate. A
recent study predicts that by the end of 2030, there will be about 22.0 million
new instances of cancer worldwide (along with roughly 13.0 million cancer
deaths). In order to improve the predictability of the oncology drug
development process, companion diagnostics are widely used. As a result, it is
anticipated that the rising incidence of cancer would encourage the adoption of
companion diagnostics for the quick development of cancer therapy medications.
The global companion diagnostics market is being stimulated by the concurrent
rise in the number of FDA-approved cancer diagnostic tests.
However, it is anticipated that throughout the projection
period, factors such as a lack of qualified specialists, high costs for
companion diagnostics, and the existence of strict government laws for product
approvals will limit the market's growth to some extent.
COMPANION DIAGNOSTICS MARKET SEGMENTATION:
By Product & Services:
· Assay
Kits & Reagents
· Software
& Services
By Technology:
· Polymerase
Chain Reaction (PCR)
· In
Situ Hybridization (ISH)
· Next-Generation
Sequencing (NGS)
· Immunohistochemistry
(IHC)
· Others
By Indication:
·
Cardiovascular
·
Neurological Diseases
·
Cancer
·
Breast Cancer
·
Lung Cancer
·
Colorectal Cancer
·
Melanoma
·
Gastric Cancer
·
Infectious Diseases
·
Others
By End User:
· Pharmaceutical
& Biopharmaceutical Companies
· Reference
Laboratories
· Contract
Research Organizations
· Others
By Region:
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East & Africa
KEY COMPANIES IN COMPANION DIAGNOSTICS
MARKET:
· Hoffmann-La
Roche AG
· Agilent
Technologies Inc.
· Biogenex
Laboratories Inc.
· Abbott
Laboratories Molecular Inc.
· ARUP
Laboratories Inc.
· BioMerieux
SA
· Danaher
Corporation
· Foundation
Medicine Inc.
· Almac
Group
· Sysmex
Corporation
· Thermo
Fisher Scientific Inc.
· Abnova
Corporation
· Guardant
Health Inc.
· Icon
Plc
· Myriad
Genetics Inc.
· Qiagen
N.V.
Read
More Information: https://www.xresearch.biz/shop/companion-diagnostics-market
About Us:-
xResearch is a market
research and consulting organization that uses unique data, expert analysis,
and new technologies to create trusted intelligence on industries. Our research
is focused on delivering an informed and impartial view on essential market
data of industry, and it is primarily driven by an in-depth study covering the
following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment